J-L Harousseau

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

F Maloisel, Lotfi Benboubker, Martine Gardembas et al. · Leukemia · 2003 · 108 citations

Medicine, Hematology, Oncology +9

Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells

Steven Le Gouill, Catherine Pellat‐Deceunynck, J-L Harousseau et al. · Leukemia · 2002 · 78 citations

Medicine, Oncology, Pharmacology +14

A multicenter prospective randomized study testing non-inferiority of thalidomide 100 mg/day as compared with 400 mg/day in patients with refractory/relapsed multiple myeloma: Results of the final analysis of the IFM 01–02 study

Ibrahim Yakoub‐Agha, Chantal Doyen, Cyrille Hulin et al. · Journal of Clinical Oncology · 2006 · 35 citations

Medicine, Pharmacology, Pharmacotherapy +17

Comparison of reduced-dose bortezomib plus thalidomide plus dexamethasone (vTD) to bortezomib plus dexamethasone (VD) as induction treatment prior to ASCT in de novo multiple myeloma (MM): Results of IFM2007-02 study.

Philippe Moreau, Thierry Façon, Michel Attal et al. · Journal of Clinical Oncology · 2010 · 30 citations

Medicine, Oncology, Pharmacology +15

LEADING ARTICLE International uniform response criteria for multiple myeloma

B. Durie, J-L Harousseau, J.S. Miguel et al. · 2006 · 25 citations

Medicine, Hematology, Oncology +10